NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 4 filers reported holding NABRIVA THERAPEUTICS AG in Q2 2017. The put-call ratio across all filers is - and the average weighting 3.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,021,559 | $23,968,000 | 7.90% |
| Omega Fund Management, LLC | 1,145,890 | $6,830,000 | 5.54% |
| ACUTA CAPITAL PARTNERS, LLC | 706,383 | $4,210,000 | 1.57% |
| Novo Holdings A/S | 2,326,544 | $13,866,000 | 1.32% |
| FT Options LLC | 83,055 | $494,000 | 0.57% |
| EcoR1 Capital, LLC | 264,773 | $1,578,000 | 0.50% |
| Boxer Capital, LLC | 176,710 | $1,053,000 | 0.41% |
| Rock Springs Capital Management LP | 525,000 | $3,124,000 | 0.21% |
| Orbimed Advisors | 1,677,940 | $10,001,000 | 0.13% |
| Hillhouse Capital Management | 700,000 | $4,165,000 | 0.09% |